Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease

Clinical Reviews in Allergy and Immunology

Volumn 43, Issue 3, 2012, Pages 265-274

  Martínez Zamora, M Ángeles ^a   Cervera, Ricard ^a   Balasch, Juan ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Recurrent miscarriage

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; PHOSPHOLIPID ANTIBODY; PROTHROMBIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN INFARCTION; CEREBRAL SINUS THROMBOSIS; DEEP VEIN THROMBOSIS; GENE MUTATION; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; LOW DRUG DOSE; LUNG EMBOLISM; PREGNANCY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RECURRENT ABORTION; SPONTANEOUS ABORTION; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS; THROMBOSIS PREVENTION; TRANSIENT ISCHEMIC ATTACK; TROPHOBLAST;

ABORTION, HABITUAL; ANTIBODIES, ANTIPHOSPHOLIPID; FEMALE; HUMANS; PREGNANCY; RISK; THROMBOEMBOLISM;

EID: 84871655395     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-012-8316-0     Document Type: Article

References (84)

1. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE et al (1988) Incidence of early loss of pregnancy. N Engl J Med 319:189-194
2. Clark DA, Coulam CB, Daya S, Chaouat G (2001) Unexplained sporadic and recurrent miscarriage in the new millennium: a critical analysis of immune mechanisms and treatments. Hum Reprod Update 7:501-511 (Pubitemid 32827551)
3. ACOG Practice Bulletin (2002) Management of recurrent early pregnancy loss. Int J Gynecol Obstet 78:179-190
4. Li TC, Markris M, Tomsu M, Tuckerman E, Laird S (2002) Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 8:463-481 (Pubitemid 35175207)
5. Rai R, Regan L (2006) Recurrent miscarriage. Lancet 368:601-611 (Pubitemid 44209184)
6. D'Uva M, Di Micco P, Strina I, De Placido G (2010) Recurrent pregnancy loss and thrombophilia. J Clin Med Rers 2:18-22
7. Eldor A (2011) Thrombophilia, thrombosis and pregnancy. Thromb Haemost 86:104-111
8. Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A (2002) Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod 17:1633-1637 (Pubitemid 34661820)
9. Prandoni P, Tormene D, Simioni P, Girolami A (2001) Venous thromboembolism, fetal loss and preclampsia in pregnant women with congenital thrombophilia. Clin Lab 47:155-159 (Pubitemid 32236963)
10. Di Micco P, D'Uva M, Strina I, De Placido G, Di Fiore R, Quarenata S et al (2007) Recurrent pregnancy loss and thrombophilia. Clin Lab 53:309-314
11. Lockwood CJ (2006) Pregnancy-Associated changes in the hemostatic system. Clin Obstet Gynecol 49:836-843 (Pubitemid 44691206)
12. Brenner B (2004) Haemostatic changes in pregnancy. Thromb Res 114:409-414 (Pubitemid 39422573)
13. Robertson L,Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD et al (2006) Thrombophilia in pregnancy: a systematic review. Br J Haematol 132:171-196 (Pubitemid 43381552)
14. Pabinger I (2009) Thrombophilia and its impact on pregnancy. Thromb Res 123:S16-S21
15. Practice Committee of the American Society for Reproductive Medicine (2008) Definitions of infertility and recurrent pregnancy loss. Fertil Steril 89:1603
16. Stephenson M, Kutteh W (2007) Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol 1:132-145 (Pubitemid 46279856)
17. Toth B, Jeschke U, Rogenhofer N, Scholz C, Würfel W, Theler CJ et al (2010) Recurrent miscarriage: current concepts in a diagnosis and treatment. J Reprod Immunol 85:25-32
18. Christiansen OB, Steffensen R, Nielsen H, Varming K (2008) Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications. Gynecol Obstet Invest 66:257-267
19. Balasch J, Font J, López-Soto A, Cervera R, Jové I, Casals FJ et al (1990) Antiphospholipid antibodies in unselected patients with repeated abortion. Hum Reprod 5:43-46 (Pubitemid 20111631)
20. Balasch J, Creus M, Fábregues F, Reverter JC, Carmona F, Tàssies D et al (1996) Antiphospholipid antibodies and human reproductive failure. Hum Reprod 11:2310-2315 (Pubitemid 26392031)
21. Balasch J, Carmona F, Creus M, Font J, Cervera R (2002) Management of reproductive failure in the antiphospholipid syndrome. In: Ashersona RA, Cervera R, Piette JC, Shoenfeld Y (eds) The antiphospholipid syndrome II: autoimmune thrombosis. Elsevier, Amsterdam, pp 375-394
22. Greaves M (2000) Antiphospholipid syndrome: state of the art with emphasis on laboratory evaluation. Haemostasis 30(Suppl 2):16-25 (Pubitemid 32234135)
23. Greaves M, Cohen H, Machin SJ, Mackie I (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 109:704-715 (Pubitemid 30609746)
24. Vinatier D, Dufour P, Cosson M, Houpeau JL (2001) Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol 96:37-50 (Pubitemid 32331848)
25. Lockshin MD (1999) Pregnancy loss in the antiphospholipid syndrome. Thromb Haemostasis 82:641-648
26. Ogasawara M, Sasa H, Katano K, Aoyama T, Aoki K, Suzumori K (1998) Recurrent abortion and moderate or strong antiphospholipid antibody production. Int J Gynecol Obstet 62:183-188 (Pubitemid 28370699)
27. Harger JH, Archer DF, Marchese SG, Muracca-Clemens M, Garver KL (1983) Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet Gynecol 62:574-581 (Pubitemid 13022126)
28. Coulam CB (1991) Epidemiology of recurrent abortion. Am J Reprod Immunol 26:23-27
29. Hatasaka HH (1994) Recurrent miscarriage: epidemiologic factors, definitions, and incidence. Clin Obstet Gynecol 37:625-634 (Pubitemid 24323541)
30. Hill JA (1994) Sporadic and recurrent spontaneous abortion. Curr Prob Obstet Gynecol Fertil 17:116-163
31. Gasbarrini A, Torre ES, Trivellini C et al (2000) Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of celiac disease. Lancet 356:399-400 (Pubitemid 30487500)
32. Barnea E (2001) Underlying mechanisms and treatment of early pregnancy failure. Ferti Magazine 33.
33. Regan L (1992) Recurrent early pregnancy failure. Curr Opin Obstet Gynecol 4:220-228
34. Regan L, Braude PB, Trembath PL (1989) Influence of past reproductive performance on risk of spontaneous abortion. Br Med J 299:541-546
35. Cauchi MN, Coulam CB, Cowchock S et al (1995) Predictive factors in recurrent spontaneous aborters -A multicenter study. Am J Reprod Immunol 33:165-170
36. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306
37. O'Riordan MN, Higgins JR (2003) Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 17:385-396 (Pubitemid 36722166)
38. Martinez-Zamora MA, Tassies D, Carmona F, Espinosa G, Cervera R, Reverter JC, Balasch J (2009) Thrombin activatable fibrinolysis inhibitor and clot lysis time in pregnant patients with antiphospholipid syndrome: relationship with pregnancy outcome and thrombosis. Am J Reprod Immunol 62:381-389
39. Bretelle F, Sabatier F, Desprez D, Camoin L, Grunebaum L, Combes V et al (2003) Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost 89:486-492 (Pubitemid 36329239)
40. Buchholz T, Thaler CJ (2003) Inherited thrombophilia: impact on human reproduction. Am J Reprod Immunol 50:20-32 (Pubitemid 36805761)
41. Rey E, Kahn SR, David M, Shrier I (2003) Thrombophilic disorders and fetal loss: a meta-Analysis. Lancet 361:901-908 (Pubitemid 36335814)
42. Kovalevsky G, Gracia CR, Berlin JA, Sammel MD, Barnhart KT (2004) Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-Analysis. Arch Intern Med 14:558-563 (Pubitemid 38314453)
43. Benedetto C, Marozio L, Tavella AM, Salton L, Grivon S, Di Giampaolo F (2010) Coagulation disorders in pregnancy: acquired and inherited thrombophilias. Ann N Y Acad Sci 1205:106-117
44. Martinelli I (2006) Thromboembolism in women. Sem Thromb Hemost 32:709-715 (Pubitemid 44623378)
45. Coulam CB, Jeyendran RS, Fishel LA, Roussev R (2006) Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol 55:360-368
46. Tulppala M, Viinikka L, Ylikorkaka O (1991) Thromboxane dominance and prostacyclin deficiency in habitual abortion. Lancet 387:879-881
47. Rai R (2003) Is miscarriage a coagulopathy? Curr Opin Obstet Gynecol 15:265-268 (Pubitemid 36677335)
48. Woodhams BJ, Candotti G, Shaw R, Kernoff PBA (1989) Changes in coagulation and fibrinolysis during pregnancy: evidence of activation of coagulation preceding spontaneous abortion. Thromb Res 55:99-107 (Pubitemid 19199170)
49. Donohoe S, Quenby S, Mackie I, Panal G, Farquharson R, Malia R et al (2002) Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-Treated antiphospholipid syndrome pregnancies. Lupus 11:11-20 (Pubitemid 34178114)
50. Martínez-Zamora MA, Creus M, Tassies D, Bové A, Reverter JC, Carmona F et al (2010) Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome. Fertil Steril 94:2437-2440
51. Marchi R, López Ramirez Y, Nagaswami C, Masova L, Pulido A, Lopez Mora J et al (2007) Haemostatic changes related to fibrin formation and fibrinolysis during the first trimester in normal pregnancy and in recurrent miscarriage. Thromb Haemost 97:552-557 (Pubitemid 46592932)
52. Gris JC, Schved JF, Neveu S, Mares P, Aguilar-Martinez P, Dupaigne D (1990) Impaired fibrinolytic capacity and early recurrent spontaneous abortion. BMJ 300:1500 (Pubitemid 20192528)
53. Gris JC, Ripart-Neveu S,Maugard C, Taillard ML, Brun S, Courtieu C et al (1997) Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. Thromb Haemost 77:1096-1103 (Pubitemid 27311976)
54. Vincent T, Rai R, Regan L, Cohen H (1998) Increased thrombin generation in women with recurrent miscarriage. Lancet 352:116 (Pubitemid 28321331)
55. Rai R, Tuddenham E, Backos M, Jivraj S, El'Gaddal S, Choy S et al (2003) Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum Reprod 18:2540-2543 (Pubitemid 37536618)
56. De Saint ML, Duchemin J, Bohec C, Couturanud F, Mottier D, Collet M et al (2011) Increased thrombin generation measured in the presence of thrombomodulin in women with early pregnancy loss. Fetil Steril 95:1813-1815
57. Smith GCS, Pell JP, Walsh D (2001) Pregnancy complications and maternal risk or ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 257:2002-2006 (Pubitemid 32592386)
58. Smith GCS, Pell JP, Walsh D (2003) Spontaneous loss of early pregnancy and risk of ischaemic heart disease in later life: retrospective cohort study. BMJ 326:423-424 (Pubitemid 36246313)
59. Ness RM, Harris T, Cobb J, Flegal KM, Kelsey JL, Balanger A et al (1993) Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med 328:1528-1533 (Pubitemid 23147782)
60. Smith GCS, Wood AM, Pell JP, Hattie J (2011) Recurrent miscarriage is associated with a family history of ischaemic heart disease: a retrospective cohort study. BJOG 118:557-563
61. Martínez-Zamora MA, Peralta S, Creus M, Tassies D, Reverter JC, Espinosa G et al (2012) Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study. Ann Rheum Dis 71:61-66
62. Simioni P, Tormene D, Spiezia L, Tognin G, Rossetto V, Radu C et al (2006) Inherited thrombophilia and venous thromboembolism. Semin Thromb Hemost 32:700-708 (Pubitemid 44623377)
63. Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY (2002) Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol 71:300-305 (Pubitemid 35396947)
64. Meroni PL (2008) Pathogenesis of the antiphospholipid syndrome: and additional example for the mosaic of autoimmunity. J Autoimmun 30:99-103
65. Meroni PL, Shoenfeld Y (2008) Predictive, protective, orphan autoantibodies: the example of anti-phospholipid antibodies. Autoimmun Rev 7:585-587
66. Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsern S, Kiss E et al (2009) Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 68:1428-1432
67. Espinosa G, Cervera R (2010) Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Nat Rev Rheumatol 6:296-300
68. Rodriguez-Garcia JL, Bertolaccini ML, Cuadrado MJ, Sanna G, Ateka-Barutia O, Khamastha MA (2012) Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called "seronegative APS"). Ann Rheum Dis 71:242-244
69. Erkan D, HarrisonMJ, Levy R, PetersonM, PetriM, Sammaritano L et al (2007) Aspirin for primary thrombosis prevention in the antiphospholipid syndrome. A randomized, double-blind, placebocontrolled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthr Rheum 56:2382-2391 (Pubitemid 47173586)
70. Hereng T, Lambert M, Samor M, Dubucquoi S, Caron C, Launay D et al (2008) Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients. Lupus 17:11-15 (Pubitemid 351487013)
71. Galli M, Luciani D, Bertolini G, Barbui T (2003) Anti-β2- glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102:2717-2723 (Pubitemid 37248837)
72. Galli M (2009) The antiphospholipid triangle. J Thromb Haemost 8:234-236
73. Tincani A, Andreoli L, Casu C, Cattaneo R, Meroni P (2010) Antiphospholipid antibody profile: implications for the evaluation and management of patients. Lupus 19:432-435
74. Urbanus RT, de Groot PG (2011) Antiphospholipid antibodies -we are not quite there yet. Blood Rev 25:97-106
75. Ruffati A, Del Ross T, Ciprian M, Nuzzo M, Rampudda M, Bertero MT et al (2009) Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study. Ann Rheum Dis 68:397-399
76. Ruffatti A, Del Ross T, Ciprian M, Bertero MT, Sciascia S, Scarpato S et al (2011) Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann Rheum Dis 70:1083-1086
77. Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD (2002) A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology 41:924-929
78. Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N et al (2010) Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 8:237-242
79. Quenby S, Farquharson RG, Dawood F, Hughes AM, Topping J (2005) Recurrent miscarriage and long-Term thrombosis risk: a case-control study. Hum Reprod 20:1729-1732 (Pubitemid 40852272)
80. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch W (1994) Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 83:372-377 (Pubitemid 24067805)
81. Tincani A, Taglietti M, Biasini C, Frassi M, Gorla R, Balestrieri G (2001) Thromboembolic events after fetal loss in patients with antiphospholipid syndrome. Arthritis Rheum 46:1126-1127
82. Erkan D, Merrill JT, Yazici Y, Sammaritano L, Buyon JP, Lockshin MD (2001) High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 44:1466-1467 (Pubitemid 32537548)
83. Gris JC, Bouvier S, Molinari GJP, Cochery-Nouvellon E, Mercier E et al (2012) Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study. Blood 119:2624-2632
84. Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F et al (2006) Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 96:337-341 (Pubitemid 44377818)